[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS5152176A - - Google Patents

Info

Publication number
JPS5152176A
JPS5152176A JP49117503A JP11750374A JPS5152176A JP S5152176 A JPS5152176 A JP S5152176A JP 49117503 A JP49117503 A JP 49117503A JP 11750374 A JP11750374 A JP 11750374A JP S5152176 A JPS5152176 A JP S5152176A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP49117503A
Other languages
Japanese (ja)
Inventor
Katsuo Arimura
Mitsuhiro Konishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Priority to JP49117503A priority Critical patent/JPS5152176A/ja
Priority to BE160739A priority patent/BE834247A/xx
Priority to NL7511857A priority patent/NL7511857A/xx
Priority to SE7511408A priority patent/SE7511408L/xx
Priority to AU85643/75A priority patent/AU8564375A/en
Priority to DE19752545501 priority patent/DE2545501A1/de
Priority to FR7531221A priority patent/FR2287228A1/fr
Publication of JPS5152176A publication Critical patent/JPS5152176A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP49117503A 1974-10-12 1974-10-12 Pending JPS5152176A (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP49117503A JPS5152176A (de) 1974-10-12 1974-10-12
BE160739A BE834247A (fr) 1974-10-12 1975-10-06 Nouveaux composes chimiques utiles en therapeutique humaine
NL7511857A NL7511857A (nl) 1974-10-12 1975-10-09 Werkwijze voor het bereiden van derivaten van ure- um of thioureum, werkwijze voor het bereiden van een geneesmiddel, die deze verbinding bevat en het volgens deze werkwijze verkregen geneesmiddel.
SE7511408A SE7511408L (sv) 1974-10-12 1975-10-10 Forfarnde for framstellning av karbamid- eller tiokarbamidderivat
AU85643/75A AU8564375A (en) 1974-10-12 1975-10-10 Urea or thiourea derivatives
DE19752545501 DE2545501A1 (de) 1974-10-12 1975-10-10 4-piperidylharnstoff- und thioharnstoff-derivate
FR7531221A FR2287228A1 (fr) 1974-10-12 1975-10-13 Nouveaux composes chimiques utiles en therapeutique humaine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49117503A JPS5152176A (de) 1974-10-12 1974-10-12

Publications (1)

Publication Number Publication Date
JPS5152176A true JPS5152176A (de) 1976-05-08

Family

ID=14713345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49117503A Pending JPS5152176A (de) 1974-10-12 1974-10-12

Country Status (7)

Country Link
JP (1) JPS5152176A (de)
AU (1) AU8564375A (de)
BE (1) BE834247A (de)
DE (1) DE2545501A1 (de)
FR (1) FR2287228A1 (de)
NL (1) NL7511857A (de)
SE (1) SE7511408L (de)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01316356A (ja) * 1987-11-27 1989-12-21 Eisai Co Ltd 環状アミン誘導体
US7393861B2 (en) * 1999-12-14 2008-07-01 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 4-aminopiperidine and their use as a medicament
US7601740B2 (en) 2003-01-16 2009-10-13 Acadia Pharmaceuticals, Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US7820695B2 (en) 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US7863296B2 (en) 2004-05-21 2011-01-04 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US9050343B2 (en) 2007-03-19 2015-06-09 Acadia Pharmaceuticals Inc. Combination of pimavanserin and risperidone for the treatment of psychosis
US10449185B2 (en) 2017-08-30 2019-10-22 Acadia Pharmaceuticals Inc. Formulations of pimavanserin
US10517860B2 (en) 2016-03-25 2019-12-31 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
US10981871B2 (en) 2015-07-20 2021-04-20 Acadia Pharmaceuticals Inc. Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C
US11135211B2 (en) 2017-04-28 2021-10-05 Acadia Pharmaceuticals Inc. Pimavanserin for treating impulse control disorder
US11464768B2 (en) 2016-12-20 2022-10-11 Acadia Pharmaceuticals Inc. Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203988A (en) 1975-11-12 1980-05-20 Merck & Co., Inc. Pyridinyl ureas and pharmaceutical use
GB1561023A (en) * 1977-04-22 1980-02-13 Beecham Group Ltd 2-methoxy - 5 - chloro aniline derivatives
US4722930A (en) * 1980-03-01 1988-02-02 John Wyeth And Brother Limited 3-benzoyl-1-[(oxo or thioheteroaryl-ylalkyl)-piperid-4-yl]ureas and derivatives
US4806552A (en) * 1980-03-01 1989-02-21 John Wyeth & Brother, Limited Pyridyl- and/or pyridoyl-(piperid-4-yl) ureas and analogues thereof
PL128510B1 (en) * 1980-03-01 1984-02-29 Wyeth John & Brother Ltd Method of obtaining new piperidine derivatives
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
AUPP818099A0 (en) 1999-01-14 1999-02-11 Fujisawa Pharmaceutical Co., Ltd. New n-containing heterocyclic compounds
WO2001068604A2 (en) * 2000-03-14 2001-09-20 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
WO2024067304A1 (zh) * 2022-09-28 2024-04-04 瀚远医药有限公司 一种具有Sigma2和5HT2A抑制活性的化合物及用途

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01316356A (ja) * 1987-11-27 1989-12-21 Eisai Co Ltd 環状アミン誘導体
US8110574B2 (en) 1999-12-14 2012-02-07 Ipsen Pharma S.A.S. Derivatives of 4-aminopiperidine and their use as a medicament
US7393861B2 (en) * 1999-12-14 2008-07-01 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 4-aminopiperidine and their use as a medicament
US9566271B2 (en) 2003-01-16 2017-02-14 Acadia Pharmaceuticals Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US8618130B2 (en) 2003-01-16 2013-12-31 Acadia Pharmaceuticals Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US10028944B2 (en) 2003-01-16 2018-07-24 Acadia Pharmaceuticals Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US7994193B2 (en) 2003-01-16 2011-08-09 Acadia Pharmaceuticals Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US8008323B2 (en) 2003-01-16 2011-08-30 Acadia Pharmaceuticals Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US7601740B2 (en) 2003-01-16 2009-10-13 Acadia Pharmaceuticals, Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US8377959B2 (en) 2003-01-16 2013-02-19 Acadia Pharmaceuticals, Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US10525046B2 (en) 2003-01-16 2020-01-07 Acadia Pharmaceuticals Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US8921393B2 (en) 2003-01-16 2014-12-30 Acadia Pharmaceuticals Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US9211289B2 (en) 2003-01-16 2015-12-15 Acadia Pharmaceuticals Inc. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US7820695B2 (en) 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US7875632B2 (en) 2004-05-21 2011-01-25 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US7863296B2 (en) 2004-05-21 2011-01-04 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US9050343B2 (en) 2007-03-19 2015-06-09 Acadia Pharmaceuticals Inc. Combination of pimavanserin and risperidone for the treatment of psychosis
US10981871B2 (en) 2015-07-20 2021-04-20 Acadia Pharmaceuticals Inc. Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C
US10981870B2 (en) 2015-07-20 2021-04-20 Acadia Pharmaceuticals Inc. Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form
US11840515B2 (en) 2015-07-20 2023-12-12 Acadia Pharmaceuticals Inc. Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c
US10517860B2 (en) 2016-03-25 2019-12-31 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
US11191757B2 (en) 2016-03-25 2021-12-07 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
US11464768B2 (en) 2016-12-20 2022-10-11 Acadia Pharmaceuticals Inc. Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis
US11135211B2 (en) 2017-04-28 2021-10-05 Acadia Pharmaceuticals Inc. Pimavanserin for treating impulse control disorder
US10646480B2 (en) 2017-08-30 2020-05-12 Acadia Pharmaceuticals Inc. Formulations of pimavanserin
US10849891B2 (en) 2017-08-30 2020-12-01 Acadia Pharmaceuticals Inc. Formulations of pimavanserin
US10449185B2 (en) 2017-08-30 2019-10-22 Acadia Pharmaceuticals Inc. Formulations of pimavanserin
US11452721B2 (en) 2017-08-30 2022-09-27 Acadia Pharmaceuticals Inc. Formulations of pimavanserin

Also Published As

Publication number Publication date
NL7511857A (nl) 1976-04-14
BE834247A (fr) 1976-02-02
AU8564375A (en) 1977-04-21
FR2287228A1 (fr) 1976-05-07
SE7511408L (sv) 1976-04-13
DE2545501A1 (de) 1976-04-22

Similar Documents

Publication Publication Date Title
FR2266729B1 (de)
DE2560628A1 (de)
FR2271453B1 (de)
JPS5152176A (de)
FR2266861B3 (de)
FR2265425B2 (de)
FR2294262B1 (de)
FR2273415B1 (de)
FR2264359B1 (de)
AU7459574A (de)
FR2272844A1 (de)
AU7462274A (de)
AU488280B2 (de)
FR2246705B3 (de)
DE2414184A1 (de)
DD112065A5 (de)
CH594170A5 (de)
BG19639A1 (de)
BG19643A1 (de)
AU482308A (de)
AU482171A (de)
BG19729A1 (de)
BG19927A1 (de)
BG19879A1 (de)
BG19908A1 (de)